Objective and research priorities
Review sample source, disease or tissue features, existing methods and the intended question to identify the one or two endpoints that matter most.
R&D service
Custom model development
Develop a model and assay plan for specialized tissues, rare diseases or complex co-cultures, starting from the samples and endpoints available to your program.
View imageCustom model studies
Build specialized models, then connect them to measurable phenotypes
Head and neck cancer culture and histology, adipose differentiation with Oil Red O, and pathology-guided GIST and osteosarcoma studies show how specialized models begin with sample context and identity QC, then progress into functional and candidate-response studies.
Study focus
Questions this study can answer
- 01How should the model strategy reflect the available samples?
- 02Which endpoints best address the current objective?
- 03How can model establishment support follow-on applications?
Study workflow
Build a model strategy around specialized samples and program goals
Custom development supports specialized tissues, rare diseases, complex co-cultures and new assays.
Representative work includes head and neck cancer organoid culture and histology, adipose differentiation and lipid accumulation, and pathology-guided mesenchymal tumor models. We design culture and assays around sample conditions, key phenotypes and intended use.
Model and assay strategy
Configure samples and conditions around culture, cellular composition, key phenotype and assay window, creating a clear path to model expansion and follow-on applications.
Result review and optimization
Use prespecified criteria to plan follow-on work and optimize culture, controls, repeatability and assay methods.
Study expansion and transfer
Use project findings to expand samples or batches and document scope, SOP, QC criteria, raw data and recommendations for future use.
Study images and readouts
Establishment, differentiation and pathology in specialized models
Head and neck cancer culture morphology and H&E, adipose phenotypes before and after differentiation, and source-tissue/model comparisons in mesenchymal tumors show how specialized models are established, checked against source tissue and prepared for functional readouts. Efficacy, mechanism or co-culture studies can then be added for the program.
View imageAdipose custom model: bright-field morphology and Oil Red O staining show a lipid-accumulation phenotype before and after differentiation, providing a measurable starting point for metabolic biology, lipid handling and candidate-response studies.
Study data
View imageCustom GIST models: bright-field culture morphology, source-tissue H&E and culture H&E compare spindle and mixed spindle/epithelioid patterns for case-specific pathology reference and model QC.
Study dataView the mesenchymal-tumor study
View imageCustom osteosarcoma models: H&E and marker panels across source tissue, PDO and primary tissue compare identity, proliferation and lineage-associated phenotypes for downstream assay selection.
Study dataView the mesenchymal-tumor studyExpected study outputs
What you receive
Study data and findings
Experimental conditions, original images or data, QC results and an explanation of the findings.
Model application & reproducibility
A clear summary of what the model can assess, available assay options and the factors that affect model establishment and reproducibility.
Methods and follow-up plan
SOPs, QC guidance and a method report, together with a plan for the next study.
Relevant model systems
Relevant model systems
Programs can start from an established model or new samples, with a clear development path built around source material, primary endpoints and critical controls before extending into efficacy, mechanism, safety or method transfer.
For BBB, ADPKD and complex co-cultures, TRiCBIO builds from kidney organoid data, HUVEC–astrocyte co-culture, tight-junction imaging and permeability methods, then adds the disease phenotype, cell source and functional readouts the program requires.
FAQ
Questions clients ask about this service
Use these answers for initial planning; models, samples, timing and deliverables are defined after scientific review in the study plan.
What can a custom organoid development project start from?
A project can start from an established model or from new tissue, cells or other suitable material. For the initial discussion, share the tissue or disease context, sample source, available methods or data, and the most important phenotype or assay objective. The team can then discuss culture, QC and follow-on applications.
How is custom model development staged and evaluated?
The study plan sets staged objectives and review criteria around the key phenotype, identity and functional QC, controls and assay window. Data from each stage inform discussion of culture conditions, reproducibility, assay methods and expansion into additional samples, so each next step is based on the results obtained.
What is typically delivered from a custom development project?
Deliverables can include experimental conditions, original images or data, model and assay QC results, an explanation of suitable applications and factors affecting reproducibility, and project-specific SOPs, QC guidance and a method report. Follow-on recommendations and the exact deliverables are defined in the study plan.
PROJECT DISCUSSION
Start with a focused project goal
A tissue or disease context, sample source and key phenotype or assay need are enough to begin. Together we can plan model establishment, QC and follow-on studies.